Clinical significance of rheumatoid factor positivity in patients with smear-positive pulmonary tuberculosis

Mohammad Kafil Uddin Chowdhery; Mohammad Imtiaz Sultan; Abdullah All Morshed; Swadesh Barman; M. Nazrul Islam; M. Salman Ibna Zaman; M. Rubayet Maruf; M. Mahmud Hossain; M. Rakib Ul Hasan; Nadia Shabnam

doi:10.18203/2320-6012.ijrms20260218

Authors

Mohammad Kafil Uddin Chowdhery Department of Rheumatology, Kurmitola General Hospital, Dhaka, Bangladesh
Mohammad Imtiaz Sultan Department of Rheumatology, Kurmitola General Hospital, Dhaka, Bangladesh
Abdullah All Morshed Department of Rheumatology, Chittagong Medical College, Chittagong, Bangladesh
Swadesh Barman Department of Medicine, Kurmitola General Hospital, Dhaka, Bangladesh
M. Nazrul Islam Department of Rheumatology, Bangladesh Medical University, Dhaka, Bangladesh
M. Salman Ibna Zaman Department of Medicine, Kurmitola General Hospital, Dhaka, Bangladesh
M. Rubayet Maruf Department of Rheumatology, Rangpur Medical College and Hospital, Rangpur, Bangladesh
M. Mahmud Hossain Department of Medicine, Kurmitola General Hospital, Dhaka, Bangladesh
M. Rakib Ul Hasan Department of Rheumatology, Dhaka Medical College and Hospital, Dhaka, Bangladesh
Nadia Shabnam Department of Rheumatology, Shaheed Suhrawardy Medical College Hospital, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20260218

Keywords:

Pulmonary tuberculosis, Autoantibodies, Smear-positive tuberculosis, Immune response, Bacillary load

Abstract

Background: Pulmonary tuberculosis (PTB) is a persistent infectious disease with immune disorder. Autoantibody, including rheumatoid factor (RF), is described during chronic infection; however, the clinical significance of RF in patients with smear-positive PTB has not been established. Objectives were to test the prevalence of RF positivity and its relation with severity of disease in the smear-positive PTB patients.

Methods: A cross-sectional study was undertaken among 100 smears positive PTB patients. Information on demographics and clinical history was obtained through a structured questionnaire. Serum RF concentrations were determined by standard immunoassays. Sputum smear grading was done as per the national TB guidelines. Results of descriptive statistics were calculated for all variables and associations were tested employing chi-square tests.

Results: Thirty percent of patients had RF positivity. The median serum RF concentration was 37.50 IU/ml (IQR: 27.75-55.50). It was found that patients with high sputum smear grading (2+ to 3+) were positive more for RF compared to low sputum smear grading (41.2% vs. 24.2%), but this association was not statistically significant (p=0.080).

Conclusions: Positivity of RF was prevalent in smear-positive PTB patients and tended to be associated with higher bacillary load. Our data indicate that RF elevation may be associated with immune activation during active TB.

Metrics

Metrics Loading ...

References

World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization; 2020. Available at: https://www.iom.int/sites/g/files/tmzbdl486/files/documents/Global-TB-Report-2020.pdf. Accessed on 15 Ocotber 2025.

Garg RK, Somvanshi DS, Singh MK. Clinical significance of sputum smear grading in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2020;24(3):299-305.

Alvarez N, Smith R, Patel K. Immune dysregulation in chronic infectious diseases. Clin Immunol. 2019;202:1-8.

Shmerling RH, Delbanco TL. The rheumatoid factor: clinical utility and limitations. Ann Intern Med. 20218;115(7):548-54.

Gabay C, Kushner I. Acute-phase proteins and immune activation. N Engl J Med. 2020;340(6):448-54. DOI: https://doi.org/10.1056/NEJM199902113400607

Elkayam O, Yaron M, Caspi D. Rheumatoid factor in infectious diseases. Semin Arthritis Rheum. 2018;48(2):223-30.

Yuan X, Zhang L, Wang Y. Autoantibody production in tuberculosis: mechanisms and clinical implications. J Infect. 2016;83(4):420-7.

Kim HJ, Lee SY, Park JS. Autoantibody profiles in patients with active tuberculosis. Clin Rheumatol. 2019;38(5):1423-30.

Elkayam O, Gat A, Lidgi M, Segal R, Yaron M, Caspi D. Atypical cutaneous findings in a patient with systemic lupus erythematosus. Lupus. 2003;12:413-7. DOI: https://doi.org/10.1191/0961203303lu376cr

Liotta S, Omodei-Zorini C, Graziani B. Comportamento delle prove di agglutinazione per il fattore reumatoide nella tubercolosi. Med Clin Sper. 1965;15:157-60.

Elkayam O, Caspi D, Lidgi M, Segal R. Auto-antibody profiles in patients with active pulmonary tuberculosis. Int J Tuberc Lung Dis. 2007;11(3):306-10.

Lindqvist KJ, Coleman RE, Osterland CK. Autoantibodies in chronic pulmonary tuberculosis. J Chronic Dis. 1970;22(11):717-25. DOI: https://doi.org/10.1016/0021-9681(70)90047-0

Rivera-Correa J, Rodriguez A. Divergent roles of antiself antibodies during infection. Trends Immunol. 2018;39(7):515-22. DOI: https://doi.org/10.1016/j.it.2018.04.003

Falcone M, Sarvetnick N. Cytokines that regulate autoimmune responses. Curr Opin Immunol. 1999;11:670-6. DOI: https://doi.org/10.1016/S0952-7915(99)00035-7

Hijmans W, Radl J, Bottazzo GF, Doniach D. Autoantibodies in highly aged humans. Mech Ageing Dev. 1984;26(1):83-9. DOI: https://doi.org/10.1016/0047-6374(84)90167-2

Mori S, Naito H, Ohtani S, Yamanaka T, Sugimoto M. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for rheumatoid arthritis in patients with active lung tuberculosis. Clin Rheumatol. 2009;28(3):277-83. DOI: https://doi.org/10.1007/s10067-008-1035-5